West Tower Group LLC raised its holdings in Enhabit, Inc. (NYSE:EHAB – Free Report) by 108.8% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 285,142 shares of the company’s stock after acquiring an additional 148,566 shares during the quarter. Enhabit makes up 4.8% of West Tower Group LLC’s holdings, making the stock its 3rd largest holding. West Tower Group LLC owned about 0.57% of Enhabit worth $2,253,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. DRW Securities LLC bought a new stake in Enhabit during the 3rd quarter valued at about $326,000. Dynamic Technology Lab Private Ltd bought a new stake in shares of Enhabit in the 3rd quarter valued at about $215,000. Intech Investment Management LLC bought a new stake in shares of Enhabit in the 3rd quarter valued at about $96,000. LMR Partners LLP bought a new stake in shares of Enhabit in the 3rd quarter valued at about $197,000. Finally, Gladius Capital Management LP raised its holdings in shares of Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after purchasing an additional 2,747 shares in the last quarter.
Wall Street Analysts Forecast Growth
Separately, Leerink Partners reiterated a “market perform” rating and set a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $9.25.
Enhabit Price Performance
Shares of EHAB opened at $7.63 on Tuesday. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $11.74. The stock has a market cap of $383.39 million, a PE ratio of -3.33 and a beta of 1.84. The firm has a 50-day simple moving average of $7.50 and a two-hundred day simple moving average of $8.38. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.
Enhabit (NYSE:EHAB – Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The business had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same quarter last year, the firm posted $0.03 EPS. As a group, analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current year.
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Featured Articles
- Five stocks we like better than Enhabit
- How to Invest in Blue Chip Stocks
- Gold’s Post-Election Moves: Key Investment Opportunities
- What Are the U.K. Market Holidays? How to Invest and Trade
- Bath & Body Works Stock Jumps 17%: Is More Growth Ahead?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Home Sales Are Rising, But Who Stands to Benefit the Most?
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.